Home LiteratureArticle Details
PMID: 9223473 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Journal of virology ·Vol. 71 ·No. 8 ·1997-08-00 ·Pages 5841-8

Srinivasakumar N, Chazal N, Helga-Maria C, Prasad S, Hammarskjöld ML, Rekosh D

Abstract

We describe the generation of stable human immunodeficiency virus type 1 (HIV-1)-packaging lines that constitutively express high levels of HIV-1 structural proteins in either a Rev-dependent or a Rev-independent fashion. These cell lines were used to assess gene transfer by using an HIV-1 vector expressing the hygromycin B resistance gene and to study the effects of Rev, Tat, and Nef on the vector titer. The Rev-independent cell lines were created by using gag-pol and env expression vectors that contain the Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE). Vector titers approaching 10(4) CFU/ml were routinely obtained with these cell lines, as well as with the Rev-dependent cell lines, with HeLa-CD4 cells as targets. The presence of Nef and Tat in the producer cell each increased the vector titer 5- to 10-fold. Rev, on the other hand, was absolutely essential for gene transfer, unless the MPMV CTE was present in the vector. In that case, by using the Rev-independent cell lines for packaging, Rev could be completely eliminated from the system without a reduction in vector titer.

MeSH Terms
Base Sequence Cell Line Gene Products, nef/physiology Gene Products, rev/physiology Gene Products, tat/physiology Gene Transfer Techniques Genetic Vectors HIV-1/genetics,physiology Humans Molecular Sequence Data Viral Structural Proteins/genetics Virus Assembly Virus Replication nef Gene Products, Human Immunodeficiency Virus rev Gene Products, Human Immunodeficiency Virus tat Gene Products, Human Immunodeficiency Virus
Chemicals
Gene Products, nef Gene Products, rev Gene Products, tat Viral Structural Proteins nef Gene Products, Human Immunodeficiency Virus rev Gene Products, Human Immunodeficiency Virus tat Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Srinivasakumar N
Myles H. Thaler Center for AIDS and Human Retrovirus Research and Department of Microbiology, University of Virginia, Charlottesville 22908, USA.
Chazal N
Helga-Maria C
Prasad S
Hammarskjöld M L
Rekosh D
References (57)
57 references, click to expand
  1. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.
    Cell. 1989 Jun 30;57(7):1155-65 PMID: 2736624
  2. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA.
    Mol Cell Biol. 1997 Jan;17(1):135-44 PMID: 8972193
  3. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.
    Cell. 1990 Mar 9;60(5):747-54 PMID: 2107024
  4. Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.
    J Virol. 1990 Apr;64(4):1690-7 PMID: 2157051
  5. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.
    J Virol. 1990 Jun;64(6):2743-50 PMID: 1692347
  6. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.
    Mol Cell Biol. 1990 Aug;10(8):4239-42 PMID: 2370865
  7. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.
    New Biol. 1992 Jan;4(1):66-74 PMID: 1536832
  8. The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity.
    Biomed Biochim Acta. 1991;50(4-6):647-53 PMID: 1801737
  9. Human immunodeficiency virus infection of cells arrested in the cell cycle.
    EMBO J. 1992 Aug;11(8):3053-8 PMID: 1322294
  10. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
    J Exp Med. 1992 Oct 1;176(4):1197-201 PMID: 1402661
  11. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
    J Virol. 1992 Nov;66(11):6547-54 PMID: 1404602
  12. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Virology. 1993 Feb;192(2):605-17 PMID: 8421902
  13. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.
    J Virol. 1993 May;67(5):2681-8 PMID: 8474168
  14. Integration of murine leukemia virus DNA depends on mitosis.
    EMBO J. 1993 May;12(5):2099-108 PMID: 8491198
  15. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.
    J Virol. 1994 Jan;68(1):510-6 PMID: 8254763
  16. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 PMID: 8108397
  17. Improved methods of retroviral vector transduction and production for gene therapy.
    Hum Gene Ther. 1994 Jan;5(1):19-28 PMID: 8155767
  18. A molecular genetic intervention for AIDS--effects of a transdominant negative form of Rev.
    Hum Gene Ther. 1994 Jan;5(1):79-92 PMID: 8155773
  19. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.
    Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15266-71 PMID: 8986799
  20. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.
    J Virol. 1997 Feb;71(2):1013-8 PMID: 8995620
  21. Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element.
    RNA. 1997 Feb;3(2):210-22 PMID: 9042947
  22. Tat is required for efficient HIV-1 reverse transcription.
    EMBO J. 1997 Mar 17;16(6):1224-35 PMID: 9135139
  23. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  24. Molecular cloning and characterization of the HTLV-III virus associated with AIDS.
    Nature. 1984 Nov 8-14;312(5990):166-9 PMID: 6095086
  25. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
    Mol Cell Biol. 1985 Feb;5(2):410-3 PMID: 2983194
  26. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
    Science. 1985 Jul 5;229(4708):69-73 PMID: 2990040
  27. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  28. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  29. New host cell system for regulated simian virus 40 DNA replication.
    Mol Cell Biol. 1985 Nov;5(11):3231-40 PMID: 3018509
  30. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector.
    Gene. 1986;43(1-2):41-50 PMID: 3019836
  31. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.
    Cell. 1987 Feb 27;48(4):691-701 PMID: 3643816
  32. Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.
    J Virol. 1987 May;61(5):1559-70 PMID: 3033283
  33. Complete nucleotide sequences of functional clones of the AIDS virus.
    AIDS Res Hum Retroviruses. 1987 Spring;3(1):57-69 PMID: 3040055
  34. Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector.
    Proc Natl Acad Sci U S A. 1988 Jan;85(2):334-8 PMID: 2829181
  35. Gene therapy. Intracellular immunization.
    Nature. 1988 Sep 29;335(6189):395-6 PMID: 3166513
  36. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.
    Nature. 1989 Mar 16;338(6212):254-7 PMID: 2784194
  37. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
    Proc Natl Acad Sci U S A. 1989 Mar;86(5):1495-9 PMID: 2784208
  38. Regulation of human immunodeficiency virus env expression by the rev gene product.
    J Virol. 1989 May;63(5):1959-66 PMID: 2704072
  39. Use of retroviral vectors for gene transfer and expression.
    Methods Enzymol. 1993;217:581-99 PMID: 8386297
  40. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.
    J Virol. 1994 Dec;68(12):7879-90 PMID: 7966578
  41. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
    J Virol. 1994 Dec;68(12):7944-52 PMID: 7966585
  42. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
    EMBO J. 1995 Feb 1;14(3):484-91 PMID: 7859737
  43. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.
    J Virol. 1995 Jul;69(7):4053-9 PMID: 7539505
  44. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.
    J Virol. 1995 Jul;69(7):4166-72 PMID: 7769676
  45. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    J Virol. 1995 Aug;69(8):5048-56 PMID: 7541845
  46. HIV accessory proteins: leading roles for the supporting cast.
    Cell. 1995 Jul 28;82(2):189-92 PMID: 7628010
  47. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Gene Ther. 1995 Jun;2(4):269-78 PMID: 7552987
  48. 5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal.
    Virology. 1995 Oct 1;212(2):718-23 PMID: 7571442
  49. Expression and purification of the HIV type 1 Rev protein produced in Escherichia coli and its use in the generation of monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1995 Aug;11(8):945-53 PMID: 7492441
  50. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
    Science. 1996 Apr 12;272(5259):263-7 PMID: 8602510
  51. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.
    J Virol. 1996 May;70(5):2963-73 PMID: 8627772
  52. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
    Virology. 1996 May 1;219(1):228-36 PMID: 8623533
  53. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
    J Virol. 1996 Jul;70(7):4283-90 PMID: 8676450
  54. Inducible human immunodeficiency virus type 1 packaging cell lines.
    J Virol. 1996 Jul;70(7):4530-7 PMID: 8676479
  55. Regulation of HIV gene expression.
    AIDS. 1995;9 Suppl A:S19-32 PMID: 8819566
  56. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14070-5 PMID: 8943062
  57. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent.
    J Virol. 1989 Sep;63(9):3865-9 PMID: 2788225
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1997-08-00
Pages
5841-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC191839
Subset
IM
Grants
NIAID NIH HHS · AI-34721 · United States
NIAID NIH HHS · AI-38186 · United States
Databases
GENBANK
J00659, K03455, M11840, M12349, M16019, M19921, M38432, M77786
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com